ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc.
ALXO
Valuace
70
Růst
0
Zdraví
75
Cena
$ 1.28
Dnes
--0.04 (-3.31%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.1B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-241%
ROA
-131%
PE
-1
PS
0
Cena 1R
0-2
⌀ Cena
0.98
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
05-03-2026
Poslední dividenda

Profil

ALX Oncology Holdings Inc., společnost zabývající se klinickým stadiem imunoonkologie, se zaměřuje na vývoj terapií pro pacienty s rakovinou. Jeho hlavním produktem je ALX148, CD47 blokující léčivo, které je v klinické studii fáze 1b/2 používané k léčbě myelodysplastických syndromů; a k léčbě akutní myeloidní leukémie a non-Hodgkinova lymfomu, stejně jako řada indikací solidních nádorů, včetně skvamózního karcinomu hlavy a krku, lidského epidermálního růstového faktoru receptor 2 (HER2) pozitivní karcinom žaludeční/gastresofageální splynutí, karcinom prsu s expresí HER2 a další solidní nádory. Předklinické produkty společnosti zahrnují ALTA-002, SIRPa TRAAC, který nabízí způsoby, jak zapojit vrozenou a adaptivní imunitní reakci na rakovinu. Společnost ALX Oncology Holdings Inc. má dohodu o spolupráci se společností Merck na studii fáze 2 hodnotící ALX148 v kombinaci s pembrolizumabem s chemoterapií a bez chemoterapie u pacientů s karcinomem hlavy a krku; společnost Zymeworks na studii fáze 1 hodnotící ALX148 s biskupskou protilátkou zanidatamab zaměřenou na HER2 u pacientů s karcinomem prsu exprimujícím HER2 a jinými solidními nádory; a společnost Tallac Therapeutics na vývoj, výrobu a komercializaci nové třídy onkologických imunoterapií. Společnost má také licenční smlouvu se společnostmi Selexis SA a Crystal Bioscience, Inc. Společnost byla založena v roce 2015 a sídlí v jižním San Francisku v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
65
Založení
2020-07-17
Adresa
323 Allerton Avenue
CEO
Jason W. Lettmann

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 20252024202320222021202020192018
Total Revenues0.000.000.000.000.000.001,182.004,796.002,067.00
Cost of Revenues0.000.000.00836.000.000.001,075.004,360.001,880.00
Gross Profit0.000.000.00-836.000.000.00107.00436.00187.00
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues0.000.000.000.000.000.000.000.002,480.000.00
Cost of Revenues0.000.000.000.000.000.00220.00214.00207.00209.00
Gross Profit0.000.000.000.000.000.00-220.00-214.002,273.00-209.00
Operating Income TTM 20252024202320222021202020192018
R&D Expenses0.000.000.00141,795.0098,400.0060,170.0028,961.0016,306.0011,270.00
Selling General & Admin Expenses0.000.000.0028,483.0029,036.0023,385.0014,809.003,313.002,601.00
Depreciation & Amortization555.000.00872.00836.00342.0084.00-404.00424.00431.00
Total Operating Expenses104,021.00100,846.00142,467.00170,278.00127,436.0083,555.0043,770.0019,619.0013,871.00
Operating Income-104,021.00-100,846.00-142,467.00-170,278.00-127,436.00-83,555.00-43,663.00-19,183.00-13,684.00
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.000.000.000.000.000.000.000.0041,784.0045,766.00
Selling General & Admin Expenses0.000.000.000.000.000.000.000.006,032.007,509.00
Depreciation & Amortization0.00153.00191.00211.00214.00224.00220.00214.00207.00209.00
Total Operating Expenses23,021.0022,532.0026,648.0031,820.0030,613.0032,567.0041,305.0037,548.0047,816.0053,275.00
Operating Income-23,021.00-22,532.00-26,648.00-31,820.00-30,613.00-32,567.00-41,525.00-37,762.00-48,023.00-53,275.00
Net Income TTM 20252024202320222021202020192018
Interest Income3,964.003,964.009,366.0010,649.004,278.000.000.000.000.00
Interest Expense1,602.001,602.001,729.001,565.00-4,360.0013.00811.0021.000.00
Other Expense2,326.00-849.007,617.009,473.004,018.0071.00-1,836.00-26.00-2.00
IBT-101,695.00-101,695.00-134,850.00-160,805.00-123,418.00-83,484.00-45,499.00-19,209.00-13,686.00
Income Tax Expense0.000.000.000.0064.00-21.00241.0034.0045.00
Net Income-101,695.00-101,695.00-134,850.00-160,805.00-123,482.00-83,463.00-45,740.00-19,243.00-13,731.00
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income573.00802.001,106.001,483.001,878.002,303.002,563.002,622.002,995.002,677.00
Interest Expense383.00408.00405.00406.00427.00446.00429.00427.00415.00391.00
Other Expense173.00388.00699.001,066.001,450.001,860.002,126.002,181.002,551.002,285.00
IBT-22,848.00-22,144.00-25,949.00-30,754.00-29,163.00-30,707.00-39,399.00-35,581.00-45,472.00-50,990.00
Income Tax Expense0.000.000.000.000.000.000.000.001,145.00-209.00
Net Income-22,848.00-22,144.00-25,949.00-30,754.00-29,163.00-30,707.00-39,399.00-35,581.00-45,472.00-50,990.00
Per Share Data TTM 20252024202320222021202020192018
EPS$0.00$0.00$0.00$-3.74$-3.03$-2.07$-2.47$-0.88$-0.63
EPS Diluted$0.00$0.00$0.00$-3.74$-3.03$-2.07$-2.47$-0.88$-0.63
Shares Outstanding54,283.5153,658.4052,174.9042,987.7740,699.6140,308.0518,485.3421,951.3621,951.36
Diluted Shares Outstanding54,283.5153,658.4052,174.9042,987.7740,699.6140,308.0518,485.3421,951.3621,951.36
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.93$-1.24
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.93$-1.24
Shares Outstanding54,283.5153,577.0753,445.6353,359.3452,802.4152,693.8851,831.1650,120.7648,996.0041,147.94
Diluted Shares Outstanding54,283.5153,577.0753,445.6353,359.3452,802.4152,693.8851,831.1650,120.7648,996.0041,147.94
Current Assets TTM 2024202320222021202020192018
Cash And Equivalents15,534.0017,567.0022,406.00282,906.00363,667.00434,219.009,017.008,262.00
Short Term Investments141,189.00110,190.00160,330.00217,385.000.000.000.000.00
Total Cash & ST Investments156,723.00127,757.00182,736.00282,906.00363,667.00434,219.009,017.008,262.00
Accounts Receivable6,240.00892.000.000.000.000.00536.00932.00
Inventory0.000.000.000.000.000.000.000.00
Other Current Assets5,749.005,703.005,923.004,762.003,352.001,773.00256.001,014.00
Total Current Assets168,712.00134,352.00188,659.00270,969.00367,019.00434,219.009,809.0010,208.00
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents23,442.0019,302.0020,614.0017,567.0016,102.0015,534.0014,041.0022,406.0019,584.0038,039.00
Short Term Investments37,184.0060,012.0077,217.00110,190.00132,472.00141,189.00143,396.00160,330.00170,425.00174,797.00
Total Cash & ST Investments60,626.0079,314.0097,831.00127,757.00148,574.00156,723.00157,437.00182,736.00196,444.00212,836.00
Accounts Receivable0.00666.00911.000.001,183.006,240.001,100.000.000.000.00
Inventory0.000.000.000.000.000.000.000.00-7,035.00-500.00
Other Current Assets5,890.005,277.003,790.006,595.006,138.005,749.009,327.005,923.009,062.006,725.00
Total Current Assets66,516.0085,257.00102,532.00134,352.00155,895.00168,712.00167,864.00188,659.00199,071.00219,561.00
Long-Term Assets TTM 2024202320222021202020192018
Net Property, Plant & Equipment10,704.009,632.0010,841.009,813.003,472.0052.00860.00956.00
Goodwill0.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.00
Long-Term Investments29,541.003,524.0035,411.0016,699.000.000.000.000.00
Other Long-Term Assets5,661.00267.007,642.009,008.009,692.001,783.007.000.00
Total Long-Term Assets45,906.0013,423.0053,894.0035,520.0013,164.001,835.00867.00956.00
Total Assets214,618.00147,775.00242,553.00306,489.00380,183.00436,054.0010,676.0011,164.00
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment1,351.001,497.008,952.009,632.0010,312.0010,704.0010,245.0010,841.009,808.009,066.00
Goodwill0.000.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.000.000.00
Long-Term Investments5,838.004,232.009,161.003,524.0014,036.0029,541.0027,115.0035,477.006,435.0011,647.00
Other Long-Term Assets9,018.004,334.00255.00267.005,472.005,661.007,426.007,576.004,793.005,658.00
Total Long-Term Assets16,207.0010,063.0018,368.0013,423.0029,820.0045,906.0044,786.0053,894.0021,036.0026,371.00
Total Assets82,723.0095,320.00120,900.00147,775.00185,715.00214,618.00212,650.00242,553.00220,107.00245,932.00
Current Liabilities TTM 2024202320222021202020192018
Accounts Payable8,146.004,497.008,591.008,073.003,764.004.003,748.00697.00
Short-Term Debt1,743.002,347.001,575.001,041.00742.000.000.000.00
Other Current Liabilities28,560.0011,656.0025,835.0019,211.00257.006,200.001,236.001,176.00
Current Liabilities38,449.0018,500.0036,001.0028,325.0015,295.006,204.004,984.001,873.00
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable6,583.004,902.003,937.004,497.007,891.008,146.006,227.008,591.0013,001.004,115.00
Short-Term Debt4,348.005,050.001,739.00435.000.001,743.001,786.001,575.000.000.00
Other Current Liabilities16,791.008,896.0013,066.0013,568.0024,449.0028,560.0024,215.0025,835.0022,141.0013,457.00
Current Liabilities27,722.0018,848.0018,742.0018,500.0032,340.0038,449.0032,228.0036,001.0035,142.0017,572.00
Long-Term Liabilities TTM 2024202320222021202020192018
Long-Term Debt9,769.0014,631.0015,622.009,389.000.000.005,421.000.00
Capital Leases5,960.007,074.007,558.001,041.00742.000.000.000.00
Def. Tax Liability0.000.000.000.000.000.000.000.00
Total Liabilities55,301.0034,157.0052,841.0043,025.0017,134.00436,054.0010,952.002,009.00
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt0.0011,132.008,232.009,469.009,835.0015,729.0015,056.0015,622.009,575.009,512.00
Capital Leases0.006,142.000.000.000.005,960.005,353.005,983.004,631.004,847.00
Def. Tax Liability0.000.000.000.000.000.000.000.000.000.00
Total Liabilities37,923.0030,905.0032,605.0034,157.0048,908.0055,301.0048,455.0052,841.0051,355.0033,240.00
Total Common Equity TTM 2024202320222021202020192018
Common Stock52.0053.0050.0041.0041.0040.003.003.00
Retained Earnings-561,252.00-621,122.00-486,272.00-325,467.00-201,985.00-118,522.00-72,782.00-53,539.00
Comprehensive Income-73.00275.00256.00-845.000.00-554,616.000.00-1,020.00
Total Common Equity159,317.00113,618.00189,712.00-325,467.00-201,985.00-118,522.00-276.009,155.00
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock54.0054.0053.0053.0053.0052.0050.0050.0041.0041.00
Retained Earnings-699,969.00-677,825.00-651,876.00-621,122.00-591,959.00-561,252.00-521,853.00-486,272.00-440,800.00-389,810.00
Comprehensive Income43.0036.00118.00275.00563.00-73.0028.00256.00-226.00-312.00
Total Common Equity44,800.0064,415.0088,295.00113,618.00136,807.00159,317.00164,195.00189,712.00-440,800.00212,692.00
Other TTM 2024202320222021202020192018
Total Debt17,472.0016,978.0017,197.0010,430.00742.000.005,421.000.00
Book Value159,317.00113,618.00189,712.00263,464.00363,049.000.00-276.009,155.00
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.000.000.000.000.000.000.000.000.000.00
Book Value44,800.0064,415.0088,295.00113,618.00136,807.00159,317.00164,195.00189,712.00-440,800.00212,692.00
Cash Flow From Operating Activities TTM 20252024202320222021202020192018
Net Income-171,442.00-101,695.00-134,850.00-160,805.00-123,482.00-83,463.00-45,740.00-19,243.00-13,731.00
Depreciation & Amortization850.00706.00872.00836.00342.0051.00202.00429.00431.00
Stock-Based Compensation27,968.0012,579.0027,093.0026,273.0023,839.0013,914.005,436.00297.00269.00
Change Working Capital12,111.00336.00-12,430.008,297.009,850.00-4,027.00247.004,257.00-159.00
Change In Accounts Receivable0.000.000.000.000.000.000.000.000.00
Change In Accounts Payable3,959.00421.00-4,024.00458.004,506.003,290.00-3,744.002,976.00-269.00
Change In Inventories0.000.000.000.000.000.000.000.000.00
Other Non-cash Items24,241.003,932.00-2,597.00-4,965.00228.005,424.00295.0011.000.00
Cash from Operations-135,327.000.000.00-130,364.00-89,223.00-68,101.00-38,289.00-14,249.00-13,190.00
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-22,848.00-22,144.00-25,949.00-30,754.00-29,163.00-30,707.00-39,399.00-35,581.00-45,472.00-50,990.00
Depreciation & Amortization151.00153.00191.00211.00214.00224.00220.00214.00207.00209.00
Stock-Based Compensation2,706.002,521.002,136.005,216.005,858.006,952.007,252.007,031.006,721.006,964.00
Change Working Capital739.002,124.00-3,172.00645.00-8,760.00-1,322.006,210.00-8,558.00331.0014,128.00
Change In Accounts Receivable0.000.000.000.000.000.000.000.000.000.00
Change In Accounts Payable-1,669.001,681.00965.00-556.00-3,781.00-194.001,883.00-2,326.00-4,484.008,886.00
Change In Inventories0.000.000.000.000.000.000.000.000.000.00
Other Non-cash Items272.00253.003,388.0019.00-195.00-523.00-849.00-1,030.0010,154.00372.00
Cash from Operations0.000.000.000.000.000.000.000.00-39,678.00-31,159.00
Cash Flow From Investing Activities TTM 20252024202320222021202020192018
Capital Expenditure917.00-212.00-447.00-1,274.00-1,427.00-4,923.00-31.00-353.00-653.00
Acquisitions50.940.000.000.000.000.000.000.000.00
Investments-222,148.00-51,593.00-107,406.00-246,629.00-376,789.000.000.000.000.00
Sales of Investment244,760.00134,391.00194,109.00292,560.00142,800.000.000.000.000.00
Other Investing Activities21.620.000.000.000.000.00641.000.000.00
Cash from Investing23,529.000.000.0044,657.00-235,416.00-4,923.00610.00-353.00-653.00
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-49.00-56.00-47.00-60.00-60.00-149.00-90.00-148.00-148.001,303.00
Acquisitions0.000.000.000.000.000.000.000.0050.940.00
Investments-5,974.00-4,442.00-25,402.00-15,775.00-4,444.00-8,713.00-62,964.00-31,285.00-75,010.00-52,889.00
Sales of Investment17,256.0025,890.0047,765.0043,480.0037,687.0034,555.0063,961.0057,906.0058,492.0064,401.00
Other Investing Activities0.000.000.000.000.000.000.000.00-16.5211.51
Cash from Investing0.000.000.000.000.000.000.000.00-16,666.0012,815.00
Cash Flow From Financing Activities TTM 20252024202320222021202020192018
Debt Repaid-567.000.000.00-388.00-388.00-281.00-6,506.000.000.00
Debt Issued8,527.0016,978.00-219.007,155.0010,076.001,023.001,085.005,421.000.00
Issuance of Common Stock89,860.000.000.0058,887.00567.000.00368,256.0010.007.00
Repurchase of Common Stock523.000.000.000.00336.00202.003.000.00-6.00
Dividends Paid0.000.000.000.000.000.00-3.000.000.00
Other Financing Activities62.490.000.00792.009,345.002,551.00101,131.0015,347.000.00
Cash from Financing89,293.000.000.0059,291.009,860.002,472.00462,881.0015,357.001.00
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.000.000.000.000.000.000.000.00-63.00-111.00
Debt Issued4,348.00-11,834.006,211.0067.0069.00-7,637.00630.00-355.007,685.00174.00
Issuance of Common Stock0.000.000.000.000.000.000.000.0059,229.000.00
Repurchase of Common Stock0.000.000.000.000.000.000.000.00523.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.000.00
Other Financing Activities0.000.000.000.000.000.000.000.0059,229.000.00
Cash from Financing0.000.000.000.000.000.000.000.0059,166.00-111.00
Cash position TTM 20252024202320222021202020192018
Net Change in Cash-22,505.00-1,194.00-4,839.00-26,416.00-314,779.00-70,552.00425,202.00755.00-13,842.00
Closing Cash Balance15,534.0016,439.0017,633.0022,472.0048,888.00363,667.00434,219.009,017.008,262.00
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-7,069.004,140.00-1,312.003,047.001,465.00568.001,493.00-8,365.002,822.00-18,455.00
Closing Cash Balance16,439.0023,508.0019,302.0020,680.0017,633.0016,168.0015,534.0014,041.0022,406.0019,650.00
Free Cash Flow TTM 20252024202320222021202020192018
Free Cash Flow-134,410.00-84,354.00-122,359.00-131,638.00-90,650.00-73,024.00-38,320.00-14,602.00-13,843.00
Real Free Cash Flow-162,378.00-96,933.00-149,452.00-157,911.00-114,489.00-86,938.00-43,756.00-14,899.00-14,112.00
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-19,029.00-17,149.00-23,453.00-24,723.00-32,106.00-25,525.00-26,656.00-38,072.00-39,826.00-29,856.00
Real Free Cash Flow-21,735.00-19,670.00-25,589.00-29,939.00-37,964.00-32,477.00-33,908.00-45,103.00-46,547.00-36,820.00
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-1.2-14.7-1.4
P/S096459170.59.4
P/B2.62.75.2
P/FCF-1.2-16.1-1.5
Market cap$0.1$2.0
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets5.3 %4.6 %0 %
Debt to Income-4.3 %-6.9 %0 %
Debt to Free cash flow-4.5 %-3772.2 %0 %
Interest expense percentage-1.5 %-0.7 %44.7 %
Current ratio2.4 14.6 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-227 %222 %0 %
ROA-122.9 %-49.2 %0 %
CapEx to Revenue0 %1707698.5 %0 %
RaD to Revenue0 %76924854.9 %0 %
ROEM0.0 22465.1

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin0 %11.3 %68.7 %
Operating margin0 %-76925364 %35.5 %
Net margin0 %-76925304.9 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %-0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding53.6 mil 39.8 mil
Employee count0.1 tis 0.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader